| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. (RNAC) has 13 insiders with recent SEC Form 4 filings, including 12 buys and 4 sells. RNAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.65M | $74.36M | - | |
| 10% | 511.6K | $4.40M | - | |
| CEO | 323.5K | $2.78M | - | |
| CFO | 121.2K | $1.04M | - | |
| Other | 94.2K | $810.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2020 | Springer Timothy A49 | Director, 10% Owner | Buy | 3,644,692 | $2.62 | $9,555,907.22 | +10.1% | |
| Oct 20, 2020 | Springer Timothy A49 | Director, 10% Owner | Buy | 1,887,696 | $2.30 | $4,336,229.62 | +6.7% | |
| Oct 9, 2020 | Springer Timothy A49 | Director, 10% Owner | Buy | 276,703 | $2.00 | $552,465.21 | +3.2% | |
| Oct 8, 2020 | Springer Timothy A49 | Director, 10% Owner | Buy | 3,185,394 | $1.71 | $5,445,212.68 | +15.1% | |
| Oct 6, 2020 | Barabe Timothy C49 | Director | Buy | 50,000 | $1.68 | $83,985.00 | +41.3% | |
| Sep 2, 2020 | Brunn Carsten86 | President And CEO | Sale+OE | 3,364 | $2.39 | $8,034.58 | -3.5% | |
| Jun 2, 2020 | Brunn Carsten86 | President And CEO | Sale+OE | 3,253 | $3.86 | $12,556.91 | -3.6% | |
| Mar 17, 2020 | Barabe Timothy C49 | Director | Buy | 5,000 | $2.00 | $10,000.00 | +6.0% | |
| Mar 3, 2020 | Brunn Carsten86 | President And CEO | Sale+OE | 3,374 | $3.86 | $13,011.49 | -4.1% | |
| Dec 2, 2019 | Brunn Carsten86 | President And CEO | Sale+OE | 14,272 | $1.53 | $21,809.04 | -16.8% |